Lloyd Matowe | |
---|---|
Occupation(s) | Pharmacist, consultant and academic |
Academic background | |
Education | B. Pharm (Hons) MSc., Clinical Pharmacology PhD., Public Health and Health Policy Diploma, Monitoring and Evaluation |
Alma mater | University of Zimbabwe University of Aberdeen Johns Hopkins University |
Academic work | |
Institutions | Manica University |
Lloyd Matowe is a pharmacist,consultant,and academic whose work centers on public health pharmacy,pharmaceutical management,and supply chains,with a particular focus on Africa. [1] He is the Director at Pharmaceutical Systems Africa (PSA),and serves as the Director and Dean of the School of Pharmacy at Manica University. Previously,he was the Dean and Founder of the School of Pharmacy at Eden University [2] and the Dean of the Faculty of Pharmacy,Nutrition and Dietetics at Lusaka Apex Medical University. Prior to moving to Zambia,he was an adjunct professor of pharmacy at the University of Iowa and Kwame Nkrumah University of Science and Technology,and served as an Honorary Professor of Pharmacy Practice at the University of Zambia. [3]
Matowe received his Bachelor of Pharmacy degree from the University of Zimbabwe in 1995 and started working as a Teaching Assistant at the same university. Later,he obtained an MSc in Clinical Pharmacology in 1997 and a PhD in Public Health and Health Policy in 2001 from the University of Aberdeen,where he also served as a lecturer in the Department of Public Health. In 2001,he became an assistant professor at Kuwait University,and received a Certificate in Program Evaluation from the Johns Hopkins Bloomberg School of Public Health in 2002. [2]
Matowe has held academic appointments at several universities,including the University of Liberia,Muhimbili University of Health and Allied Sciences,Kwame Nkrumah University of Science and Technology,the University of Zambia,the University of Iowa,and the University of Zimbabwe. He has assumed administrative roles,serving as the Dean of the Faculty of Pharmacy at Lusaka Apex Medical University from 2018 to 2019,and was the Dean of the School of Pharmacy at Eden University from 2020 to 2023. In 2024,he founded Manica University,a medical university in Lusaka,Zambia,where he served as Director and the first Dean of the School of Pharmacy. [2]
Matowe was appointed Operations Research and Capacity Building Manager at Management Sciences for Health from 2005 to 2009,establishing Centers of Excellence for Pharmaceutical Supply Chain Management in East Africa. From 2009 to 2011,he led the Market Dynamics workstream of the Affordable Medicines Facility-Malaria at The Global Fund. [4] Since 2017,he has served as the chair for People that Deliver Coalition [3] as well as the Director at Pharmaceutical Systems Africa. From 2022 to 2024,he also served as the Chief Editor for the Pharmaceutical Journal of Zambia .
Matowe has focused on various aspects of pharmaceutical systems,including capacity development,policy analysis,pharmacovigilance,rational use of medicines,supply chain management,procurement,and quality assurance. [1]
Matowe has researched healthcare policies and their implementation throughout his career. In a highly cited collaborative study,he reviewed guideline development and implementation strategies,assessing their effectiveness and costs,and proposed a framework for efficient guideline introduction,emphasizing the need for further research in healthcare decision-making. [5] He also evaluated the quality of interrupted time series (ITS) designs in implementation research,revealing common methodological flaws and advocating for enhanced standards. [6]
Matowe investigated the high prevalence of self-medication with antibiotics and antimalarials in Khartoum State,Sudan,identifying socio-economic factors associated with this behavior and highlighting its implications for public health policy. [7] In a similar study conducted in Kuwait,he observed high self-medication rates among adolescents,with pain relief being the most common,and parents serving as the main source of medication information. [8] He further assessed hypertension medication access and non-compliance in Ghana,revealing that 93% of patients interviewed were non-compliant,mainly due to unaffordable drug prices. [9]
Matowe's work on clinical pharmacotherapy focused on therapeutic research and healthcare quality improvement. One of his early studies investigated the correlation between thiopurine methyltransferase genotype and azathioprine toxicity in rheumatic disease patients,proposing its potential for predicting and mitigating acute adverse effects. [10] In another collaborative study published in The Lancet,he assessed strategies to decrease radiological test requests by general practitioners. The findings revealed that incorporating educational reminders led to a reduction of about 20% in requests,whereas audit and feedback showed minimal impact,resulting in only a 1% decrease. [11]
Matowe explored approaches to improve supply chain management effectiveness in Africa. [12] In Liberia,he worked on improving pharmacy education by developing a new curriculum with a supply chain management focus and appointing a Dean. [13]
A medication is a drug used to diagnose,cure,treat,or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
A pharmacist,also known as a chemist in Commonwealth English,is a healthcare professional who is knowledgeable about preparation,mechanism of action,clinical usage and legislation of medications in order to dispense them safely to the public and to provide consultancy services. A pharmacist also often serves as a primary care provider in the community and offers services,such as health screenings and immunizations.
Allopurinol is a medication used to decrease high blood uric acid levels. It is specifically used to prevent gout,prevent specific types of kidney stones and for the high uric acid levels that can occur with chemotherapy. It is taken orally or intravenously.
Pharmacy is the science and practice of discovering,producing,preparing,dispensing,reviewing and monitoring medications,aiming to ensure the safe,effective,and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting,pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.
Azathioprine,sold under the brand name Imuran,among others,is an immunosuppressive medication. It is used for the treatment of rheumatoid arthritis,granulomatosis with polyangiitis,Crohn's disease,ulcerative colitis,and systemic lupus erythematosus;and in kidney transplants to prevent rejection. It is listed by the International Agency for Research on Cancer as a group 1 human carcinogen. It is taken by mouth or injected into a vein.
Self-medication,sometime called do-it-yourself (DIY) medicine, is a human behavior in which an individual uses a substance or any exogenous influence to self-administer treatment for physical or psychological conditions,for example headaches or fatigue.
An adverse drug reaction (ADR) is a harmful,unintended result caused by taking medication. ADRs may occur following a single dose or prolonged administration of a drug or may result from the combination of two or more drugs. The meaning of this term differs from the term "side effect" because side effects can be beneficial as well as detrimental. The study of ADRs is the concern of the field known as pharmacovigilance. An adverse event (AE) refers to any unexpected and inappropriate occurrence at the time a drug is used,whether or not the event is associated with the administration of the drug. An ADR is a special type of AE in which a causative relationship can be shown. ADRs are only one type of medication-related harm. Another type of medication-related harm type includes not taking prescribed medications,known as non-adherence. Non-adherence to medications can lead to death and other negative outcomes. Adverse drug reactions require the use of a medication.
Mercaptopurine (6-MP),sold under the brand name Purinethol among others,is a medication used for cancer and autoimmune diseases. Specifically it is used to treat acute lymphocytic leukemia (ALL),acute promyelocytic leukemia (APL),Crohn's disease,and ulcerative colitis. For acute lymphocytic leukemia it is generally used with methotrexate. It is taken orally.
Thiopurine methyltransferase or thiopurine S-methyltransferase (TPMT) is an enzyme that in humans is encoded by the TPMT gene. A pseudogene for this locus is located on chromosome 18q.
Pharmacotherapy,also known as pharmacological therapy or drug therapy,is defined as medical treatment that utilizes one or more pharmaceutical drugs to improve ongoing symptoms,treat the underlying condition,or act as a prevention for other diseases (prophylaxis).
Tioguanine,also known as thioguanine or 6-thioguanine (6-TG) or tabloid is a medication used to treat acute myeloid leukemia (AML),acute lymphocytic leukemia (ALL),and chronic myeloid leukemia (CML). Long-term use is not recommended. It is given by mouth.
A veterinary pharmacist is a specially trained pharmacist who dispenses veterinary drugs and supplies or products and advice to owners of companion animals and livestock. In addition,they advise the regulatory bodies and are involved in the formulation of veterinary drugs. Veterinary pharmacy is a field of pharmacy practice,in which veterinary pharmacists may compound medications,fill prescriptions,and manage drug therapies for animals. Veterinary pharmacists are licensed pharmacists who specialize in the distribution of medications for animals.
Pharmaceutical care is a pharmacy practice model developed in the 1990s that describes patient-centered medication management services performed by pharmacists.
A counterfeit medication or a counterfeit drug is a medication or pharmaceutical item which is produced and sold with the intent to deceptively represent its origin,authenticity,or effectiveness. A counterfeit drug may contain inappropriate quantities of active ingredients,or none,may be improperly processed within the body,may contain ingredients that are not on the label,or may be supplied with inaccurate or fake packaging and labeling. Counterfeit drugs are related to pharma fraud. Drug manufacturers and distributors are increasingly investing in countermeasures,such as traceability and authentication technologies,to try to minimise the impact of counterfeit drugs. Antibiotics with insufficient quantities of an active ingredient add to the problem of antibiotic resistance.
The environmental effect of pharmaceuticals and personal care products (PPCPs) is being investigated since at least the 1990s. PPCPs include substances used by individuals for personal health or cosmetic reasons and the products used by agribusiness to boost growth or health of livestock. More than twenty million tons of PPCPs are produced every year. The European Union has declared pharmaceutical residues with the potential of contamination of water and soil to be "priority substances".[3]
The term environmental persistent pharmaceutical pollutants (EPPP) was first suggested in the nomination in 2010 of pharmaceuticals and environment as an emerging issue in a Strategic Approach to International Chemicals Management (SAICM) by the International Society of Doctors for the Environment (ISDE). The occurring problems from EPPPs are in parallel explained under environmental impact of pharmaceuticals and personal care products (PPCP). The European Union summarizes pharmaceutical residues with the potential of contamination of water and soil together with other micropollutants under "priority substances".
Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals classified as high-cost,high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused. They are used to treat complex or rare chronic conditions such as cancer,rheumatoid arthritis,hemophilia,H.I.V. psoriasis,inflammatory bowel disease and hepatitis C. In 1990 there were 10 specialty drugs on the market,around five years later nearly 30,by 2008 200,and by 2015 300.
Kelly Chibale PhD,MASSAf,FAAS,Fellow of UCT,FRSSAf,FRSC is professor of organic chemistry at the University of Cape Town,and the founder and director of H3D research center and H3D Foundation NPC. In 2018 he was recognised as one of Fortune magazine's top 50 World's Greatest Leaders. His research focuses on drug discovery and the development of tools and models to contribute to improving treatment outcomes in people of African descent or heritage.
Professor Paul Waako,is a Ugandan pharmacologist,academic and academic administrator,who serves as the Vice Chancellor of Busitema University,a public university in the Eastern Region of Uganda,since 1 May 2019.
Omnicell,Inc. is an American multinational healthcare technology company headquartered in Fort Worth,Texas. It manufactures automated systems for medication management in hospitals and other healthcare settings,and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.